United States Recombinant DNA Vaccines Market Report 2016

September 2016 | 120 pages | ID: U29A4F5BBADEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Recombinant DNA Vaccines

Revenue, means the sales value of Recombinant DNA Vaccines

This report studies sales (consumption) of Recombinant DNA Vaccines in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• ALK - Abello A/S (Denmark)
• Altimmune, Inc. (US)
• Bavarian Nordic A/S (Denmark)
• BiondVax Pharmaceuticals Ltd. (Israel)
• Bharat Biotech International Limited (India)
• GlaxoSmithKline Plc. (UK)
• Hualan Biological Engineering Inc. (China)
• Janssen Pharmaceuticals, Inc. (US)
• MedImmune (US)
• Merck & Co., Inc. (US)
• Pfizer Inc. (US)
• Sanofi Pasteur SA (France)
• Serum Institute of India Pvt. Ltd. (India)
• Shanghai BravoBio Co., Ltd. (China)
• Seqirus (UK)
• SK Chemicals Co., Ltd. (Korea)
• Takeda Pharmaceutical Company Limited (Japan)
• Zydus Cadila (India)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Recombinant DNA Vaccines in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Recombinant DNA Vaccines Market Report 2016

1 RECOMBINANT DNA VACCINES OVERVIEW

1.1 Product Overview and Scope of Recombinant DNA Vaccines
1.2 Classification of Recombinant DNA Vaccines
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Recombinant DNA Vaccines
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Recombinant DNA Vaccines (2011-2021)
  1.4.1 USA Recombinant DNA Vaccines Sales and Growth Rate (2011-2021)
  1.4.2 USA Recombinant DNA Vaccines Revenue and Growth Rate (2011-2021)

2 USA RECOMBINANT DNA VACCINES COMPETITION BY MANUFACTURERS

2.1 USA Recombinant DNA Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Recombinant DNA Vaccines Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Recombinant DNA Vaccines Average Price by Manufactures (2015 and 2016)
2.4 Recombinant DNA Vaccines Market Competitive Situation and Trends
  2.4.1 Recombinant DNA Vaccines Market Concentration Rate
  2.4.2 Recombinant DNA Vaccines Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA RECOMBINANT DNA VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA Recombinant DNA Vaccines Sales and Market Share by Type (2011-2016)
3.2 USA Recombinant DNA Vaccines Revenue and Market Share by Type (2011-2016)
3.3 USA Recombinant DNA Vaccines Price by Type (2011-2016)
3.4 USA Recombinant DNA Vaccines Sales Growth Rate by Type (2011-2016)

4 USA RECOMBINANT DNA VACCINES SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA Recombinant DNA Vaccines Sales and Market Share by Application (2011-2016)
4.2 USA Recombinant DNA Vaccines Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA RECOMBINANT DNA VACCINES MANUFACTURERS PROFILES/ANALYSIS

5.1 ALK - Abello A/S (Denmark)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Recombinant DNA Vaccines Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 ALK - Abello A/S (Denmark) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Altimmune, Inc. (US)
  5.2.2 Recombinant DNA Vaccines Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Altimmune, Inc. (US) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Bavarian Nordic A/S (Denmark)
  5.3.2 Recombinant DNA Vaccines Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Bavarian Nordic A/S (Denmark) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 BiondVax Pharmaceuticals Ltd. (Israel)
  5.4.2 Recombinant DNA Vaccines Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 BiondVax Pharmaceuticals Ltd. (Israel) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Bharat Biotech International Limited (India)
  5.5.2 Recombinant DNA Vaccines Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Bharat Biotech International Limited (India) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 GlaxoSmithKline Plc. (UK)
  5.6.2 Recombinant DNA Vaccines Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 GlaxoSmithKline Plc. (UK) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Hualan Biological Engineering Inc. (China)
  5.7.2 Recombinant DNA Vaccines Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Hualan Biological Engineering Inc. (China) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Janssen Pharmaceuticals, Inc. (US)
  5.8.2 Recombinant DNA Vaccines Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Janssen Pharmaceuticals, Inc. (US) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 MedImmune (US)
  5.9.2 Recombinant DNA Vaccines Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 MedImmune (US) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Merck & Co., Inc. (US)
  5.10.2 Recombinant DNA Vaccines Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Merck & Co., Inc. (US) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Pfizer Inc. (US)
5.12 Sanofi Pasteur SA (France)
5.13 Serum Institute of India Pvt. Ltd. (India)
5.14 Shanghai BravoBio Co., Ltd. (China)
5.15 Seqirus (UK)
5.16 SK Chemicals Co., Ltd. (Korea)
5.17 Takeda Pharmaceutical Company Limited (Japan)
5.18 Zydus Cadila (India)

6 RECOMBINANT DNA VACCINES MANUFACTURING COST ANALYSIS

6.1 Recombinant DNA Vaccines Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Recombinant DNA Vaccines

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Recombinant DNA Vaccines Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Recombinant DNA Vaccines Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA RECOMBINANT DNA VACCINES MARKET FORECAST (2016-2021)

10.1 USA Recombinant DNA Vaccines Sales, Revenue Forecast (2016-2021)
10.2 USA Recombinant DNA Vaccines Sales Forecast by Type (2016-2021)
10.3 USA Recombinant DNA Vaccines Sales Forecast by Application (2016-2021)
10.4 Recombinant DNA Vaccines Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Recombinant DNA Vaccines
Table Classification of Recombinant DNA Vaccines
Figure USA Sales Market Share of Recombinant DNA Vaccines by Type in 2015
Table Application of Recombinant DNA Vaccines
Figure USA Sales Market Share of Recombinant DNA Vaccines by Application in 2015
Figure USA Recombinant DNA Vaccines Sales and Growth Rate (2011-2021)
Figure USA Recombinant DNA Vaccines Revenue and Growth Rate (2011-2021)
Table USA Recombinant DNA Vaccines Sales of Key Manufacturers (2015 and 2016)
Table USA Recombinant DNA Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant DNA Vaccines Sales Share by Manufacturers
Figure 2016 Recombinant DNA Vaccines Sales Share by Manufacturers
Table USA Recombinant DNA Vaccines Revenue by Manufacturers (2015 and 2016)
Table USA Recombinant DNA Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Recombinant DNA Vaccines Revenue Share by Manufacturers
Table 2016 USA Recombinant DNA Vaccines Revenue Share by Manufacturers
Table USA Market Recombinant DNA Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Recombinant DNA Vaccines Average Price of Key Manufacturers in 2015
Figure Recombinant DNA Vaccines Market Share of Top 3 Manufacturers
Figure Recombinant DNA Vaccines Market Share of Top 5 Manufacturers
Table USA Recombinant DNA Vaccines Sales by Type (2011-2016)
Table USA Recombinant DNA Vaccines Sales Share by Type (2011-2016)
Figure USA Recombinant DNA Vaccines Sales Market Share by Type in 2015
Table USA Recombinant DNA Vaccines Revenue and Market Share by Type (2011-2016)
Table USA Recombinant DNA Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Recombinant DNA Vaccines by Type (2011-2016)
Table USA Recombinant DNA Vaccines Price by Type (2011-2016)
Figure USA Recombinant DNA Vaccines Sales Growth Rate by Type (2011-2016)
Table USA Recombinant DNA Vaccines Sales by Application (2011-2016)
Table USA Recombinant DNA Vaccines Sales Market Share by Application (2011-2016)
Figure USA Recombinant DNA Vaccines Sales Market Share by Application in 2015
Table USA Recombinant DNA Vaccines Sales Growth Rate by Application (2011-2016)
Figure USA Recombinant DNA Vaccines Sales Growth Rate by Application (2011-2016)
Table ALK - Abello A/S (Denmark) Basic Information List
Table ALK - Abello A/S (Denmark) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure ALK - Abello A/S (Denmark) Recombinant DNA Vaccines Sales Market Share (2011-2016)
Table Altimmune, Inc. (US) Basic Information List
Table Altimmune, Inc. (US) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Altimmune, Inc. (US) Recombinant DNA Vaccines Sales Market Share (2011-2016)
Table Bavarian Nordic A/S (Denmark) Basic Information List
Table Bavarian Nordic A/S (Denmark) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bavarian Nordic A/S (Denmark) Recombinant DNA Vaccines Sales Market Share (2011-2016)
Table BiondVax Pharmaceuticals Ltd. (Israel) Basic Information List
Table BiondVax Pharmaceuticals Ltd. (Israel) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table BiondVax Pharmaceuticals Ltd. (Israel) Recombinant DNA Vaccines Sales Market Share (2011-2016)
Table Bharat Biotech International Limited (India) Basic Information List
Table Bharat Biotech International Limited (India) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bharat Biotech International Limited (India) Recombinant DNA Vaccines Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Recombinant DNA Vaccines Sales Market Share (2011-2016)
Table Hualan Biological Engineering Inc. (China) Basic Information List
Table Hualan Biological Engineering Inc. (China) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hualan Biological Engineering Inc. (China) Recombinant DNA Vaccines Sales Market Share (2011-2016)
Table Janssen Pharmaceuticals, Inc. (US) Basic Information List
Table Janssen Pharmaceuticals, Inc. (US) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Pharmaceuticals, Inc. (US) Recombinant DNA Vaccines Sales Market Share (2011-2016)
Table MedImmune (US) Basic Information List
Table MedImmune (US) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table MedImmune (US) Recombinant DNA Vaccines Sales Market Share (2011-2016)
Table Merck & Co., Inc. (US) Basic Information List
Table Merck & Co., Inc. (US) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co., Inc. (US) Recombinant DNA Vaccines Sales Market Share (2011-2016)
Table Pfizer Inc. (US) Basic Information List
Table Pfizer Inc. (US) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Inc. (US) Recombinant DNA Vaccines Sales Market Share (2011-2016)
Table Sanofi Pasteur SA (France) Basic Information List
Table Sanofi Pasteur SA (France) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Pasteur SA (France) Recombinant DNA Vaccines Sales Market Share (2011-2016)
Table Serum Institute of India Pvt. Ltd. (India) Basic Information List
Table Serum Institute of India Pvt. Ltd. (India) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Serum Institute of India Pvt. Ltd. (India) Recombinant DNA Vaccines Sales Market Share (2011-2016)
Table Shanghai BravoBio Co., Ltd. (China) Basic Information List
Table Shanghai BravoBio Co., Ltd. (China) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shanghai BravoBio Co., Ltd. (China) Recombinant DNA Vaccines Sales Market Share (2011-2016)
Table Seqirus (UK) Basic Information List
Table Seqirus (UK) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Seqirus (UK) Recombinant DNA Vaccines Sales Market Share (2011-2016)
Table SK Chemicals Co., Ltd. (Korea) Basic Information List
Table SK Chemicals Co., Ltd. (Korea) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table SK Chemicals Co., Ltd. (Korea) Recombinant DNA Vaccines Sales Market Share (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List
Table Takeda Pharmaceutical Company Limited (Japan) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Recombinant DNA Vaccines Sales Market Share (2011-2016)
Table Zydus Cadila (India) Basic Information List
Table Zydus Cadila (India) Recombinant DNA Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zydus Cadila (India) Recombinant DNA Vaccines Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant DNA Vaccines
Figure Manufacturing Process Analysis of Recombinant DNA Vaccines
Figure Recombinant DNA Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Recombinant DNA Vaccines Major Manufacturers in 2015
Table Major Buyers of Recombinant DNA Vaccines
Table Distributors/Traders List
Figure USA Recombinant DNA Vaccines Production and Growth Rate Forecast (2016-2021)
Figure USA Recombinant DNA Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table USA Recombinant DNA Vaccines Production Forecast by Type (2016-2021)
Table USA Recombinant DNA Vaccines Consumption Forecast by Application (2016-2021)